MyFinsight
Home
Blog
About
Back
Income Statement
Verrica Pharmaceuticals Inc. (VRCA)
Verrica Pharmaceuticals Inc. (VRCA)
source: myfinsight.com
Net (loss) income
-$13,153K
(-6547.55%↓ Y/Y)
Product
$5,093K
(12.33%↑ Y/Y)
License And
Collaboration Revenue
$769K
(-90.59%↓ Y/Y)
(loss) income from
operations
-$13,097K
(-967.35%↓ Y/Y)
Total other expense,
net
-$56K
(95.71%↑ Y/Y)
Total revenue
$5,862K
(-53.85%↓ Y/Y)
Interest income
$111K
(-51.32%↓ Y/Y)
Total operating
expenses
$18,959K
(69.40%↑ Y/Y)
Interest expense
$164K
(-92.30%↓ Y/Y)
Other expense
-$3K
(-200.00%↓ Y/Y)
Selling, general and
administrative
$10,349K
(16.91%↑ Y/Y)
Research and development
$6,034K
(226.87%↑ Y/Y)
Legal settlement, net
of insurance...
-$1,698K
Cost of license and
collaboration revenue
$443K
Cost of product
revenue
$435K
(27.94%↑ Y/Y)
Back